by TractManager | Dec 21, 2020 | Health Technology Assessment
Focus of the Report: This report focuses on the efficacy and safety of the 5-hydroxytryptamine 1F (5-HT1F) receptor agonist lasmiditan (Reyvow) for acute treatment of migraines.Technology Description: The 5-HT1F receptors are found on secondary trigeminal neurons, the...
by TractManager | Dec 21, 2020 | Emerging Technology Report
The bridge-enhanced anterior cruciate ligament (ACL) repair (BEAR) implant is a proprietary bio-engineered bridging scaffold made from bovine collagen. It is intended to facilitate healing of a complete ACL tear. It was developed as an alternative to the current...
by TractManager | Dec 21, 2020 | Molecular Test Assessment
The report evaluates the analytical validity, clinical validity, and clinical utility of the VeriStrat test, a liquid biopsy-based proteomic test that identifies a chronic inflammatory immune response indicative of aggressive disease in patients with advanced...
by TractManager | Dec 17, 2020 | Health Technology Assessment
Focus of the Report: This report focuses on the efficacy and safety of the calcitonin gene-related peptide (CGRP) receptor antagonist ubrogepant (Ubrelvy) for acute treatment of migraines.Technology Description: Ubrogepant is approved for the acute treatment of...
by TractManager | Dec 15, 2020 | News
The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) has issued an interim recommendation for use of the Pfizer-BioNTech COVID-19 vaccine.On December 11, 2020, the Food and Drug Administration (FDA) issued an...
Recent Comments